TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Number and type of treatment emergent adverse events (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in resting-state functional Magnetic Resonance Imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Self-selected Gait Speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: insulin need per kg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of toxicities related to CAR19 therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Cure rate of POD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Parental Monitoring
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in Parental Communication
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in Family Assessment Task Interaction Ratings
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in Proportion of Days Used Over the Past 90 Days Outside of a Controlled Environment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Substance Use Problems
Endpoint domain: Adverse events/effects
Primary endpoint: Modified Rankin scale score at 3 months
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Symptomatic intracerebral haemorrhage (ICH) and neurological deterioration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Perceived Cognitive Impairments Scale (PCI)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Verbal Memory (VBM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Symbol Digit Coding (SDC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Stroop Test (ST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 4-Part Continuous Performance Test (FPCPT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Total Plasma Ceramides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: EHMRGscore
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in laboratory safety tests: hematology: hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Visual Analog Scale-Pain (EVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of patients who had postoperative complication
Endpoint domain: Adverse events/effects
Primary endpoint: Total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Total N-nitrosonornicotine (NNN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Physiological accuracy of X-ray-based ventilation imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with local and systemic adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with unsolicited AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with abnormal results in hematology parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Visual Analog Scale for Anxiety (VAS-A) Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in weekly minutes of moderate-vigorous intensity physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of use ≥3 days/week
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Frequency of use on ≥70% of study days
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time to device explantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: biochemically-validated abstinence rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in proportion of participants who are exclusively breastfeeding
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in proportion of participants who are any breastfeeding
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mini-Mental State Examination (MMSE) score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Wechsler Memory Scale-III (WMS-III) score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage Fat Mass (FM) (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Validity and reliability of QLPSD
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Motor Evoked Potentials (MEPs) in First Dorsal Interosseous (FDI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in Spinal Reflex Threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Threshold For Detecting Passive Joint Movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in inflammation marker level: CRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Lipid status, change in Total cholesterol, LDL, HDL and triglycerides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Recurrence of SVT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants with adverse events after injection
Endpoint domain: Adverse events/effects
Primary endpoint: Likelihood of patient-physician discussion of hearing loss
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Likelihood of patient-physician discussion of hearing assessment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Numeric Rating Scale for Pain of Dominant Change (NRS for DC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Range of Motion (ROM) of the wrist
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: PRWE Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes in near vision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postprandial triglycerides concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: postprandial free fatty acid concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: postprandial glycerol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Minimum clinically important difference (MCID)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: blood flow response to acetylcholine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: blood flow response to insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of discontinuations due to AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in Length/Height-for-age z-scores (zHAZ) at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in Length/Height-for-age z-scores (zHAZ) at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in extensor leg strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in flexor leg strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in range of motion following knee replacement surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Extent of wound exudate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Late wound dehiscence or wound discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Formation of wound complications (superficial and deep wound infection)
Endpoint domain: Adverse events/effects
Primary endpoint: Reaching the daily caloric goal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence and severity of adverse events (AE), serious adverse events (SAE), and adverse events leading to withdrawal
Endpoint domain: Adverse events/effects
Primary endpoint: Clinically significant change from baseline in 12-lead electrocardiogram (ECG) findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Assessment of urinary bladder wall
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Proportion of Ultrasound that Agree with Fluoroscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in hearing on the implanted ear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved speech recognition on the implanted ear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confirmed response at 50%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postpartum Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Post-partum PTSD
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Post-partum depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Differences in serum metabolomics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Differences in skeletal muscle metabolomics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Differences in steroid metabolomics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in performance of Stroop Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in performance of Stop Signal Task Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in performance of N-Back task/2-Back task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: BV recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaginal pH Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Verbal fluency: Semantic
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Verbal fluency: Phonemic
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discourse Analysis: Story Retell
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and type of contacts with health care providers
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number and type of interventions and/or procedures
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number and type of medications and therapies
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Accuracy of spectrophotometer in determining mineralization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in HbA1c (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area under receiver operating curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of Sustained Interferon Alfa 2b Therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of uptake of oncologic risk reducing mastectomies
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Depression, Anxiety, Stress Scale (DASS21)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: The World Health Organization quality of life-BREF questionnaire (WHOQOL-BREF)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Symptoms of sub-acute bowel obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: change in 3D dimension of skull
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of moderate-to-severe postoperative pain
Endpoint domain: Adverse events/effects
Primary endpoint: urine albumin/creatinine ratio (UACR) reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Symptomatic arterial thromboembolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Geometric mean titer (GMT) of serum anti-SARS-CoV-2 neutralizing antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric mean increase (GMI) of serum anti-SARS-CoV-2 neutralizing antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroconversion rate (SCR) of serum IgG antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: changes in skin manifestations of photodamage (global score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Inflammatory cytokine levels in the blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cyst resolution or reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The absolute value of eGFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Changes in 24-hour urinary protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Plasma Concentration of Probe Substrates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-year bDFS
Endpoint domain: Mortality/survival
Primary endpoint: Ratings of discomfort of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: successful imaging of biliary system
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: operation duration
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: intra-operative complications (bleeding, bile duct leakage, bile duct injury)
Endpoint domain: Adverse events/effects
Primary endpoint: Abdominal pain intensity response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stool consistency response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Frequency of patients with a Peth concentration greater than 200 µg/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intracranial disease free survival
Endpoint domain: Mortality/survival
Primary endpoint: Dual Remission of Depression and Insomnia
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Effectiveness on migraine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of metformin in aging intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of condomless anal sex acts with a casual partner
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Changes in bacterial species in feces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Short chain fatty acids in stool
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Dyadic Adjustment Scale (DAS-32 and DAS-4)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Couple Satisfaction Inventory (CSI-16)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Experiences in Close Relationships Questionnaire (ECR-36)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Attitudes Towards Serious Mental Illness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: First Face knowledge assessment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Perceived Competence to Respond
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: TCI personality dimensions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinical cardiopulmonary toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Participants' self-efficacy regarding the job search process
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Participants' job search intensity and effort
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: The quality of participants' job search behaviors
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Residual tumor burden classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Prevalence of joint complaints
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: genes or proteins compatible with drug targeting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: novel biomarkers specific to patient population
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Hepatitis C viral load results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiation dermatitis grading change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Burden scale for Family Caregiver
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Post traumatic stress (PTSD) in caregivers
Endpoint domain: Adverse events/effects
Primary endpoint: Anxiety and Depression in caregivers
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Bifidobacterium longum and Pediococcus pentosaceus levels in feces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Hamilton Depression Rating Scale-17 (HAM-D-17) Scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Retinal detachment rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with NRS score greater than one
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: External / Internal rotation ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lift-off test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neers test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hawkins and kennedy test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified QuickDASH questionnaire result
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Electroencephalography evoked response amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Near infrared spectroscopy evoked response amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Grey matter volume in the somatosensory cortex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Frontal-parietal structural connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Frontal-parietal functional connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Quality of cognitive development
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Increase dentine thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of hair loss amount
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of hair density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of hair follicle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facial Appearance Change
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Wijma Birth Expectancy / Experience Scale (W-DEQ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in tissue oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Polyunsaturated fatty acids in adipose tissue lipids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Child's pain change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EC50 of DEX
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 95% CI of DEX
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunogenicity of subunit KLH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes